Medical Doctor Program year 2021 Source: CMS Open Payments, 2026 publication

Jennifer Peugh

Rheumatology Cleveland, OH Medical Doctor

NPI 1124477179 CMS profile 3462500

9500 Euclid Ave, 3601 Fifth Ave, Cleveland, OH 44195

Open in the dashboard

General payments

$53

1 record reported · program year 2021

Research payments

$0

Paid to them · None reported · program year 2021

Ownership & investment interest

$0

None reported

Through program year 2021, Jennifer Peugh of Cleveland, OH is reported in the CMS Open Payments database as having received $53 across 1 general payment and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 6th percentile of Rheumatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2021 General $53 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Peugh
  • Rheumatology median
  • Middle half of Rheumatology
  • National median

In program year 2025, general payments to Jennifer Peugh were reported at $0. Among 4,454 Rheumatology profiles paid that year, the median was $903 and the middle half received between $171 and $2,775.

Show as a table
Year Jennifer Peugh Rheumatology median Middle half National median
2019 $0 $744 $153–$2,687 $163
2020 $0 $462 $98–$2,027 $114
2021 $53 $531 $101–$2,153 $132
2022 $0 $627 $125–$2,303 $149
2023 $0 $741 $145–$2,524 $160
2024 $0 $830 $166–$2,660 $164
2025 $0 $903 $171–$2,775 $169

Breakdown

Who paid General payments · program year 2021
  1. Janssen Biotech, Inc. $53 1 payment

Every payment, record by record

What the payments were for General payments · program year 2021
  1. Education $53 1 payment
Products named General payments · program year 2021
  1. TREMFYA $53 1 payment
  2. SIMPONI ARIA $53 1 payment
  3. STELARA $53 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

535

Median for Rheumatology: 1,511

Drug cost

$329,807

Median for Rheumatology: $1,139,948

Branded share of claims

22.6%

Median for Rheumatology: 28.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Humira(Cf) Pen Adalimumab Brand 23 $156,514
Forteo Teriparatide Brand 22 $87,035
Orencia Clickject Abatacept Brand 13 $72,852
Hydroxychloroquine Sulfate Generic 166 $6,449
Methotrexate Methotrexate Sodium Brand 63 $2,399
Leflunomide Generic 26 $1,736
Colchicine Generic 20 $1,209
Prednisone Generic 110 $544
Gabapentin Generic 23 $333
Alendronate Sodium Generic 33 $287

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,224 Part D prescribers listed as Rheumatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$17,351

Medicare's payments for the services billed

Medicare patients

132

Average age 72

Services billed

302

94 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 64%
Osteoporosis 46%
Depression 27%
Chronic kidney disease 23%
Diabetes 22%
Ischemic heart disease 22%
Cancer 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Rheumatology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record